Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source

News articleYahoo Finance· January 12, 2026

NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery

View original at finance.yahoo.com

NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery NVIDIA NVIDIA BioNeMoNVIDIA today announced a major expansion of NVIDIA BioNeMo, an open development platform that enables lab-in-the-loop workflows to develop breakthroughs in AI-driven biology and drug discovery…

Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

Artificial intelligence coupled with laboratory automation will transform how scientific work is performed
80% confidence
The collaboration can help customers work faster, improve accuracy and get more value out of each experiment
80% confidence
Lilly is moving toward a future where discovery is driven by rapid experimentation and increasingly customized models
80% confidence
The co-innovation lab is a catalyst for capabilities that will define the next era of drug discovery
80% confidence
Biology and drug discovery are reaching their transformer moments
80% confidence
BioNeMo turns experimental data into usable intelligence for AI, creating a continuous learning cycle that speeds up discovery
80% confidence

NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery

What we drew from this source

Cited in these Via News reports